comparemela.com
  1. Home
  2. Live Updates
  3. Glycemic Data - Breaking News

Latest Breaking News On - Glycemic data - Page 1 : comparemela.com

Biomea Fusion Presents Long-Term Follow-Up Data Showing Improved Glycemic Control after 22 Weeks Off Treatment in Ongoing Phase II Study (COVALENT-111) of BMF-219 in Adults with Type 2 Diabetes in a Poster Presentation at the World Congress Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC)

BMF-219 is an investigational novel covalent menin inhibitor developed to regenerate insulin-producing beta cells with the aim to cure diabetes At Week 26, 22 weeks after the last dose of BMF-219,.

United statesExchange commissionSecurities exchangeClinical updateMultiple ascending doseGlycemic dataPharmacokinetic dataEx vivo human islet dataSecurities actSecurities exchange actExchange actBiomea fusion

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.